Yixintang Pharmaceutical Group Co., Ltd. (SHE:002727)
China flag China · Delayed Price · Currency is CNY
12.78
+0.05 (0.39%)
May 8, 2026, 3:04 PM CST

SHE:002727 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
2,5472,3023,4183,6763,5122,235
Short-Term Investments
---219.66--
Trading Asset Securities
749.88759.84--8.36297.3
Cash & Short-Term Investments
3,2973,0623,4183,8953,5202,532
Cash Growth
-4.39%-10.40%-12.26%10.66%39.00%-17.16%
Accounts Receivable
1,6431,5631,6131,5551,7761,376
Other Receivables
296.54284.22319.49313.3307.29206.63
Receivables
1,9401,8471,9321,8682,0831,583
Inventory
3,6733,6734,0883,8533,3873,317
Prepaid Expenses
--3.491.030.140.16
Other Current Assets
316.38364.71270.29275.63467.06260.12
Total Current Assets
9,2268,9479,7129,8939,4587,692
Property, Plant & Equipment
3,3923,5743,9563,9513,9944,080
Long-Term Investments
140.4131.4136.52143.26352.46107.22
Goodwill
1,9611,9611,9831,6501,3971,380
Other Intangible Assets
274.68277.08196.86178.08165.67122.89
Long-Term Deferred Tax Assets
101.51102.0493.788.9494.1158.46
Long-Term Deferred Charges
536.46556.44724.03661.17629.9590.75
Other Long-Term Assets
53.458.692982.3188.59305.71
Total Assets
15,68515,60816,83016,64716,17914,337
Accounts Payable
4,4544,4364,9164,3394,3293,806
Accrued Expenses
227.99252.24539.54681.48518.75295.38
Short-Term Debt
534.41519.46495.57468.6402.57127.7
Current Portion of Long-Term Debt
824.34851-1.80.24.02
Current Portion of Leases
--1,005975.88932.771,012
Current Income Taxes Payable
136.98144.8253.6281.37197.86118.4
Current Unearned Revenue
141.01101.83116.9113.72156.61105.18
Other Current Liabilities
541.51559.08504.61537.55339.23415.09
Total Current Liabilities
6,8616,8647,6317,2006,8775,884
Long-Term Debt
----1.835.08
Long-Term Leases
1,1691,2661,5311,5521,7571,729
Long-Term Unearned Revenue
17.3516.2911.5514.5412.1513.34
Long-Term Deferred Tax Liabilities
3.223.33.553.934.053.56
Total Liabilities
8,0508,1509,1778,7708,6527,665
Common Stock
585.6585.6585.6596.01596.02596.18
Additional Paid-In Capital
2,0132,0132,0192,1442,1472,157
Retained Earnings
5,0394,8634,8865,0114,7003,869
Treasury Stock
-150-150--4.24-22.69-46.86
Comprehensive Income & Other
-8.15-8.23--6.192.93
Total Common Equity
7,4797,3037,4917,7467,4266,578
Minority Interest
155.86153.84162.27131.04101.4494.8
Shareholders' Equity
7,6357,4577,6537,8777,5286,673
Total Liabilities & Equity
15,68515,60816,83016,64716,17914,337
Total Debt
2,5272,6373,0312,9983,0942,908
Net Cash (Debt)
769.21425.47386.58896.84425.94-375.58
Net Cash Growth
114.52%10.06%-56.90%110.56%--
Net Cash Per Share
1.330.740.651.500.72-0.63
Filing Date Shares Outstanding
585.63548.6585.6596.01596.02596.18
Total Common Shares Outstanding
585.63548.6585.6596.01596.02596.18
Working Capital
2,3652,0822,0802,6932,5811,809
Book Value Per Share
12.7713.3112.7913.0012.4611.03
Tangible Book Value
5,2435,0655,3115,9185,8635,075
Tangible Book Value Per Share
8.959.239.079.939.848.51
Buildings
--892.7894.92785.07741.03
Machinery
--447.47416.9385.35350.85
Construction In Progress
--35.799.813.8725.47
Source: S&P Global Market Intelligence. Standard template. Financial Sources.